Suchergebnisse - "Venkatakrishnan, Karthik"

PubPharm (354)

91

Population pharmacokinetic and exposure‐response analyses from ALTA‐1L : Model‐based analyses supporting the brigatinib dose in ALK‐positive NSCLC

enthalten in: Clinical and Translational Science | 2022

von Gupta, N. | Reckamp, K. | Camidge, D. | +8

92

Alternatives to rifampicin : A review and perspectives on the choice of strong CYP3A inducers for clinical drug–drug interaction studies

enthalten in: Clinical and Translational Science | 2022

von Bolleddula, J. | Gopalakrishnan, S. | Hu, P. | +2

93

Population Pharmacokinetics and Exposure‐Safety Relationships of Alisertib in Children and Adolescents With Advanced Malignancies

enthalten in: The Journal of Clinical Pharmacology | 2022

von Zhou, X. | Mould, D. | Yuan, Y. | +4

94

Population Pharmacokinetics of Ponatinib in Healthy Adult Volunteers and Patients With Hematologic Malignancies and Model‐Informed Dose Selection for Pediatric Development

enthalten in: The Journal of Clinical Pharmacology | 2022

von Hanley, M. | Diderichsen, P. | Narasimhan, N. | +3

95

Designing phase I oncology dose escalation using dose–exposure–toxicity models as a complementary approach to model‐based dose–toxicity models

enthalten in: CPT: Pharmacometrics & Systems Pharmacology | 2022

von Pantoja, K. | Lanke, S. | Munafo, A. | +6

96

Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumab

enthalten in: CPT: Pharmacometrics & Systems Pharmacology | 2022

von Terranova, N. | French, J. | Dai, H. | +9

97

Population pharmacokinetic/pharmacodynamic joint modeling of ixazomib efficacy and safety using data from the pivotal phase III TOURMALINE‐MM1 study in multiple myeloma patients

enthalten in: CPT: Pharmacometrics & Systems Pharmacology | 2022

von Srimani, J. | Diderichsen, P. | Hanley, M. | +3

98

Model-Informed Drug Development : Connecting the Dots With a Totality of Evidence Mindset to Advance Therapeutics

enthalten in: Clinical pharmacology and therapeutics | 2021

von Venkatakrishnan, K. | van der Graaf, P.

99

Effect of severe renal impairment on the pharmacokinetics of brigatinib

enthalten in: Investigational new drugs | 2021

von Gupta, N. | Hanley, M. | Kerstein, D. | +4

100

Effects of Itraconazole and Rifampin on the Pharmacokinetics of Mobocertinib (TAK-788), an Oral Epidermal Growth Factor Receptor Inhibitor, in Healthy Volunteers

enthalten in: Clinical pharmacology in drug development | 2021

von Zhang, S. | Jin, S. | Griffin, C. | +4